Tina Kaffenberger

Tina Kaffenberger

Auto-generated profile, based on publicly available information

Tina Kaffenberger

Stroke Theme, The Florey Institute of Neuroscience and Mental Health (T.K., J.B., V.N.T., H.J., B.C.V.C.), University of Melbourne, Australia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in NeuroImage
Verified
Journal Article
Closed access
UHUwe Herwig
Uwe Herwig
TKTina Kaffenberger
Tina Kaffenberger
LJLutz Jäncke
Lutz Jäncke
ABAnnette Brühl
Annette Brühl

1 August 2007 in NeuroImage
Verified
Journal Article
Closed access
UHUwe Herwig
Uwe Herwig
TBThomas Baumgartner
Thomas Baumgartner
TKTina Kaffenberger
Tina Kaffenberger
ABAnnette Brühl
Annette Brühl
MKMara Kottlow
Mara Kottlow
MRMichael Rufer
Michael Rufer

1 March 2011 in Brain Research
Verified
Journal Article
Closed access
ABAnnette Brühl
Annette Brühl
MRMichael Rufer
Michael Rufer
ADAba Delsignore
Aba Delsignore
TKTina Kaffenberger
Tina Kaffenberger
LJLutz Jäncke
Lutz Jäncke
UHUwe Herwig
Uwe Herwig

1 November 2021 in Stroke
Verified
Journal Article
Closed access
PDF file
KHKathryn S. Hayward
Kathryn S. Hayward
SKSharon F. Kramer
Sharon F. Kramer
EDEmily J. Dalton
Emily J. Dalton
GHGemma R. Hughes
Gemma R. Hughes
ABAmy Brodtmann
Amy Brodtmann
JBJulie Bernhardt
Julie Bernhardt
This systematic review aimed to investigate timing, dose, and efficacy of upper limb intervention during the first 6 months poststroke. Three online databases were searched up to July 2020. Titles/abstracts/full-text were reviewed independently by 2 authors. Randomized and nonrandomized studies that enrolled people within the first 6 months poststroke, aimed to improve upper limb recovery, and completed preintervention and postintervention assessments were included. Risk of bias was assessed using Cochrane reporting tools. Studies were examined by timing (recovery epoch), dose, and intervention type. Two hundred and sixty-one studies were included, representing 228 (n=9704 participants) unique data sets. The number of studies completed increased from one (n=37 participants) between 1980 and 1984 to 91 (n=4417 participants) between 2015 and 2019. Timing of intervention start has not changed (median 38 days, interquartile range [IQR], 22–66) and study sample size remains small (median n=30, IQR 20–48). Most studies were rated high risk of bias (62%). Study participants were enrolled at different recovery epochs: 1 hyperacute (<24 hours), 13 acute (1–7 days), 176 early subacute (8–90 days), 34 late subacute (91–180 days), and 4 were unable to be classified to an epoch. For both the intervention and control groups, the median dose was 45 (IQR, 600–1430) min/session, 1 (IQR, 1–1) session/d, 5 (IQR, 5–5) d/wk for 4 (IQR, 3–5) weeks. The most common interventions tested were electromechanical (n=55 studies), electrical stimulation (n=38 studies), and constraint-induced movement (n=28 studies) therapies. Despite a large and growing body of research, intervention dose and sample size of included studies were often too small to detect clinically important effects. Furthermore, interventions remain focused on subacute stroke recovery with little change in recent decades. A united research agenda that establishes a clear biological understanding of timing, dose, and intervention type is needed to progress stroke recovery research. Prospective Register of Systematic Reviews ID: CRD42018019367/CRD42018111629.

1 January 2007 in NeuroImage
Verified
Journal Article
Closed access
UHUwe Herwig
Uwe Herwig
TKTina Kaffenberger
Tina Kaffenberger
TBThomas Baumgartner
Thomas Baumgartner
LJLutz Jäncke
Lutz Jäncke

21 October 2009 in Neuropsychopharmacology
Verified
Journal Article
Closed access
ABAnnette Brühl
Annette Brühl
TKTina Kaffenberger
Tina Kaffenberger
UHUwe Herwig
Uwe Herwig